##  [Novartis to present first IL-17A Phase III data for AIN457 (secukinumab) in psoriatic arthritis and ankylosing spondylitis at ACR 2014](/us-en/news/media-releases/novartis-present-first-il-17a-phase-iii-data-ain457-secukinumab-psoriatic-arthritis-and-ankylosing-spondylitis-acr-2014-0 "Novartis to present first IL-17A Phase III data for AIN457 (secukinumab) in psoriatic arthritis and ankylosing spondylitis at ACR 2014") 

  Nov 10, 2014